Back to top
more

Molina Healthcare (MOH)

(Real Time Quote from BATS)

$349.52 USD

349.52
186,118

-2.83 (-0.80%)

Updated May 14, 2024 03:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 21% (52 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Brookdale (BKD) Down 3% Post Q1 Earnings: What Lies Ahead?

by Zacks Equity Research

Elevated facility operating costs and lower interest income strain Brookdale's (BKD) Q1 results, which were partly offset by favorable occupancy rates fetching improved resident fees.

Pediatrix (MD) Q1 Earnings Beat on Hospital Contract Fees

by Zacks Equity Research

Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.

Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat

by Zacks Equity Research

Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.

Acadia Healthcare (ACHC) Shares Down 9% Despite Q1 Earnings Beat

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q1 results aided by improved revenue per patient day, partly offset by escalating costs. It continues to expect 2024 adjusted EPS within $3.40-$3.70.

Ensign Group (ENSG) Stock Down 2.4% Despite Q1 Earnings Beat

by Zacks Equity Research

Ensign Group (ENSG) expects revenues between $4.13 and $4.17 billion, the mid-point of which indicates an improvement of 11.3% from the 2023 figure.

Cigna (CI) Q1 Earnings Beat on Client Wins in Evernorth Unit

by Zacks Equity Research

Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.

Tenet Healthcare (THC) Beats on Q1 Earnings, Ups '24 EPS View

by Zacks Equity Research

Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.

Encompass Health (EHC) Stock Down Despite Q1 Earnings Beat

by Zacks Equity Research

Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.

HCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions

by Zacks Equity Research

HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.

Centene (CNC) Q1 Earnings Beat on Premiums, '24 EPS View Hiked

by Zacks Equity Research

Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.

Community Health (CYH) Q1 Earnings Top on Better Occupancy Rates

by Zacks Equity Research

Community Health's (CYH) first-quarter results benefit from improved occupancy and reimbursement rates. However, declining admissions partially offset the positives.

Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership

by Zacks Equity Research

Molina Healthcare's (MOH) Q1 results reflect strong premium revenue growth. It continues to estimate adjusted EPS at a minimum of $23.50 for 2024.

Universal Health (UHS) Q1 Earnings Beat on Rising Patient Days

by Zacks Equity Research

Universal Health's (UHS) first-quarter results benefit from improved patient days in both segments. However, higher expenses partially offset the positives.

Molina (MOH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Debasmita Chatterjee headshot

Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss?

by Debasmita Chatterjee

Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.

Countdown to Molina (MOH) Q1 Earnings: Wall Street Forecasts for Key Metrics

by Zacks Equity Research

Get a deeper insight into the potential performance of Molina (MOH) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Will High Medical Care Ratios Hurt Molina's (MOH) Q1 Earnings?

by Zacks Equity Research

Molina's (MOH) first-quarter performance is likely to have been hurt by escalating medical care costs, partly offset by growing membership in all three businesses.

Molina (MOH) Wins Deal to Serve Michigan's Medicaid Members

by Zacks Equity Research

Molina Healthcare (MOH) wins a Medicaid contract from the MDHHS to better care for the healthcare needs of Michigan's Medicaid beneficiaries and therefore, gain more customers.

Centene (CNC) Wins Medicaid Contract to Better Serve Michigan

by Zacks Equity Research

Centene's (CNC) Meridian secures a contract from the Michigan Department of Health and Human Services, which gives it the opportunity to better serve the health needs of the state's Medicaid members.

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXH

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Evaluating Molina Healthcare's (MOH) Future View: Hold or Fold?

by Zacks Equity Research

Molina Healthcare's (MOH) top line is poised to gain from rising premium revenues and investment income.

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

by Zacks Equity Research

Sector ETF report for FXH

Molina (MOH) Up 2.7% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers

by Zacks Equity Research

The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.